ACCEPT SIMS AI™

AI-enabled screening intelligence and navigation

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,273
Screening encounters
5,107
Diagnostic referrals
968
Outstanding pathways
323

Screening pathway

  1. Screening5,107Encounters
  2. Positive finding1,762Documented findings
  3. Referral968Diagnostic referrals
  4. Follow-up1,168Diagnostic visits
  5. Outcome645Resolved pathways

Stage totals use different units. Pending pathways: 323. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 1908 · EXP-1908Synthetic · Site D

Full participant history through 2027-02-10, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Repeat plan · HPV DNA · Prior HPV positive · Scheduled for 2026-03-22
  4. · Screening · HPV DNA · Repeat · Prior HPV positive
  5. · Screening result · HPV DNA · HPV detected · Adequate
  6. · Diagnostic referral · EXP-1908-T-R
  7. · Contact attempt · Unsuccessful
  8. · Diagnostic booking · Initial booking
  9. · Contact attempt · Reached
  10. · Diagnostic visit · Attended
  11. · Diagnosis · Colposcopy · Biopsy collected
  12. · Diagnosis · Histopathology · No high-grade lesion identified
  13. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-05-19
  14. · Follow-up disposition · Resolved · EXP-1908-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

4273 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0286 · Expanded synthetic participant 0286Site A — Urban Referral Hub
EXP-0287 · Expanded synthetic participant 0287Site E — Resource-Constrained Navigation Programme
EXP-0289 · Expanded synthetic participant 0289Site C — Rural Outreach Programme
EXP-0291 · Expanded synthetic participant 0291Site B — Peri-Urban Access Programme
EXP-0292 · Expanded synthetic participant 0292Site D — Community Engagement Programme
EXP-0293 · Expanded synthetic participant 0293Site E — Resource-Constrained Navigation Programme
EXP-0297 · Expanded synthetic participant 0297Site A — Urban Referral Hub
EXP-0298 · Expanded synthetic participant 0298Site C — Rural Outreach Programme
EXP-0299 · Expanded synthetic participant 0299Site B — Peri-Urban Access Programme
EXP-0300 · Expanded synthetic participant 0300Site A — Urban Referral Hub
EXP-0301 · Expanded synthetic participant 0301Site D — Community Engagement Programme
EXP-0302 · Expanded synthetic participant 0302Site D — Community Engagement Programme
EXP-0303 · Expanded synthetic participant 0303Site D — Community Engagement Programme
EXP-0304 · Expanded synthetic participant 0304Site B — Peri-Urban Access Programme
EXP-0307 · Expanded synthetic participant 0307Site A — Urban Referral Hub
EXP-0308 · Expanded synthetic participant 0308Site E — Resource-Constrained Navigation Programme
EXP-0311 · Expanded synthetic participant 0311Site E — Resource-Constrained Navigation Programme
EXP-0312 · Expanded synthetic participant 0312Site D — Community Engagement Programme
EXP-0313 · Expanded synthetic participant 0313Site A — Urban Referral Hub
EXP-0314 · Expanded synthetic participant 0314Site A — Urban Referral Hub
EXP-0315 · Expanded synthetic participant 0315Site B — Peri-Urban Access Programme
EXP-0316 · Expanded synthetic participant 0316Site D — Community Engagement Programme
EXP-0317 · Expanded synthetic participant 0317Site D — Community Engagement Programme
EXP-0318 · Expanded synthetic participant 0318Site B — Peri-Urban Access Programme
EXP-0319 · Expanded synthetic participant 0319Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
1930
HPV DNA
2465
Cytology
712

Navigation activity

Barrier documented
875
Contact attempt
1410
Navigation intervention
381
Diagnostic booking
1206
Diagnostic visit
1168

Documented barriers

Contact difficulty
281
Transport difficulty
287
Appointment coordination
307

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.